Company Filing History:

12 out of 4,179

Abbott Laboratories Corporation

patents

7 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

Years Active: 1976-1988

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4760060 - 3-heteroaralkylthio carbacephem compounds and antibacterial (1988-07-26),

2. 4683220 - Novel physiologically active substances K-26, a process for preparation (1987-07-28),

3. 4640919 - 3-substituted carbacepem compounds having antibacterial effect (1987-02-03),

4. 4575497 - 3, 3', 4'-Tri-O-acylspiramycin I (1986-03-11),

5. 4522812 - Novel physiologically active substance K-4, a process for preparation (1985-06-11),

6. 4316957 - Process for the production of 7-deazaadenosine and 7-deazainosine (1982-02-23),

7. 4310661 - Antibiotics XK-62-3 and XK-62-4 and process for production thereof (1982-01-12),

8. 4298690 - Antibiotics XK-62-3 and XK-62-4 and process for production thereof (1981-11-03),

9. 4216308 - Fortimicin factors D and KE compounds (1980-08-05),

10. 4209612 - Fortimicin factors KF and KG and process for production thereof (1980-06-24),

11. 4162305 - Antibiotic XK-99 and process for production thereof (1979-07-24),

12. 4145253 - Process for producing fortimicin factors (1979-03-20),

13. 4097428 - Fortimicin C and process for production thereof (1978-06-27),

14. 4048015 - Fortimicin C and process for production thereof (1977-09-13),

15. 4045610 - Antibiotics designated XK-88 series (1977-08-30),

Title: Ryo Okachi: Innovator in Antibacterial Compounds

Introduction

Ryo Okachi is a notable inventor based in Machida, Japan, recognized for his significant contributions to the field of pharmaceuticals. With a robust portfolio of 19 patents, he has been instrumental in developing innovative compounds aimed at combatting bacterial infections.

Latest Patents

His latest inventions include the 3-heteroaralkylthio carbacephem compounds that exhibit strong antibacterial activity against both Gram-positive and Gram-negative bacteria. These compounds have a specific formula that incorporates various organic and inorganic groups, making them valuable for treating a range of infections. Another recent patent is for a novel physiologically active substance known as K-26, which is described as a hypotensive agent. This substance comes with a detailed process for its preparation and potential pharmaceutical applications.

Career Highlights

Ryo Okachi's career has been marked by his collaborations with prominent organizations. Notably, he has worked with Abbott Laboratories and Kyowa Hakko Kogyo Co., Ltd., where he contributed to significant advancements in pharmaceutical development. His expertise in medicinal chemistry and dedication to innovation have positioned him as a leading figure in his field.

Collaborations

Throughout his career, Ryo has partnered with esteemed colleagues such as Takashi Nara and Isao Kawamoto. These collaborations have facilitated the exchange of ideas and fostered a productive environment for innovation, further enhancing the quality and impact of his inventions.

Conclusion

Ryo Okachi exemplifies the spirit of innovation through his dedication to developing new antibacterial compounds and therapeutic agents. His work continues to play a critical role in advancing healthcare solutions and addressing the growing concerns of antibiotic resistance in modern medicine. As a prolific inventor, Okachi's contributions will undoubtedly influence the pharmaceutical landscape for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com